92 related articles for article (PubMed ID: 38671536)
21. UniProt: the Universal Protein Knowledgebase in 2023.
UniProt Consortium
Nucleic Acids Res; 2023 Jan; 51(D1):D523-D531. PubMed ID: 36408920
[TBL] [Abstract][Full Text] [Related]
22. KEGG for taxonomy-based analysis of pathways and genomes.
Kanehisa M; Furumichi M; Sato Y; Kawashima M; Ishiguro-Watanabe M
Nucleic Acids Res; 2023 Jan; 51(D1):D587-D592. PubMed ID: 36300620
[TBL] [Abstract][Full Text] [Related]
23. Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial.
González-Martín A; Desauw C; Heitz F; Cropet C; Gargiulo P; Berger R; Ochi H; Vergote I; Colombo N; Mirza MR; Tazi Y; Canzler U; Zamagni C; Guerra-Alia EM; Levaché CB; Marmé F; Bazan F; de Gregorio N; Dohollou N; Fasching PA; Scambia G; Rubio-Pérez MJ; Milenkova T; Costan C; Pautier P; Ray-Coquard I;
Eur J Cancer; 2022 Oct; 174():221-231. PubMed ID: 36067615
[TBL] [Abstract][Full Text] [Related]
24. Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer.
Wu Q; Tu H; Li J
Front Pharmacol; 2022; 13():914730. PubMed ID: 35837284
[TBL] [Abstract][Full Text] [Related]
25. Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.
Biermann J; Melms JC; Amin AD; Wang Y; Caprio LA; Karz A; Tagore S; Barrera I; Ibarra-Arellano MA; Andreatta M; Fullerton BT; Gretarsson KH; Sahu V; Mangipudy VS; Nguyen TTT; Nair A; Rogava M; Ho P; Koch PD; Banu M; Humala N; Mahajan A; Walsh ZH; Shah SB; Vaccaro DH; Caldwell B; Mu M; Wünnemann F; Chazotte M; Berhe S; Luoma AM; Driver J; Ingham M; Khan SA; Rapisuwon S; Slingluff CL; Eigentler T; Röcken M; Carvajal R; Atkins MB; Davies MA; Agustinus A; Bakhoum SF; Azizi E; Siegelin M; Lu C; Carmona SJ; Hibshoosh H; Ribas A; Canoll P; Bruce JN; Bi WL; Agrawal P; Schapiro D; Hernando E; Macosko EZ; Chen F; Schwartz GK; Izar B
Cell; 2022 Jul; 185(14):2591-2608.e30. PubMed ID: 35803246
[TBL] [Abstract][Full Text] [Related]
26. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
Front Genet; 2022; 13():862264. PubMed ID: 35711946
[TBL] [Abstract][Full Text] [Related]
27. Role of Amino Acid Transporter SNAT1/SLC38A1 in Human Melanoma.
Böhme-Schäfer I; Lörentz S; Bosserhoff AK
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565278
[TBL] [Abstract][Full Text] [Related]
28. PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity.
Hoffmann C; Noel F; Grandclaudon M; Massenet-Regad L; Michea P; Sirven P; Faucheux L; Surun A; Lantz O; Bohec M; Ye J; Guo W; Rochefort J; Klijanienko J; Baulande S; Lecerf C; Kamal M; Le Tourneau C; Guillot-Delost M; Soumelis V
Nat Commun; 2022 Apr; 13(1):1983. PubMed ID: 35418195
[TBL] [Abstract][Full Text] [Related]
29. Cytokine and Chemokine Receptor Patterns of Human Malignant Melanoma Cell Lines.
Koroknai V; Szász I; Jámbor K; Balázs M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269787
[TBL] [Abstract][Full Text] [Related]
30. Cellular architecture of human brain metastases.
Gonzalez H; Mei W; Robles I; Hagerling C; Allen BM; Hauge Okholm TL; Nanjaraj A; Verbeek T; Kalavacherla S; van Gogh M; Georgiou S; Daras M; Phillips JJ; Spitzer MH; Roose JP; Werb Z
Cell; 2022 Feb; 185(4):729-745.e20. PubMed ID: 35063085
[TBL] [Abstract][Full Text] [Related]
31. Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.
Xie R; Li B; Jia L; Li Y
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054979
[TBL] [Abstract][Full Text] [Related]
32. Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway.
Yang P; Chen W; Xu H; Yang J; Jiang J; Jiang Y; Xu G
Cancer Cell Int; 2021 Nov; 21(1):635. PubMed ID: 34844613
[TBL] [Abstract][Full Text] [Related]
33. Monocytes secrete CXCL7 to promote breast cancer progression.
Wang YH; Shen CY; Lin SC; Kuo WH; Kuo YT; Hsu YL; Wang WC; Lin KT; Wang LH
Cell Death Dis; 2021 Nov; 12(12):1090. PubMed ID: 34789744
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Tawbi HA; Forsyth PA; Hodi FS; Algazi AP; Hamid O; Lao CD; Moschos SJ; Atkins MB; Lewis K; Postow MA; Thomas RP; Glaspy J; Jang S; Khushalani NI; Pavlick AC; Ernstoff MS; Reardon DA; Kudchadkar R; Tarhini A; Chung C; Ritchings C; Durani P; Askelson M; Puzanov I; Margolin KA
Lancet Oncol; 2021 Dec; 22(12):1692-1704. PubMed ID: 34774225
[TBL] [Abstract][Full Text] [Related]
35. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.
Wu T; Hu E; Xu S; Chen M; Guo P; Dai Z; Feng T; Zhou L; Tang W; Zhan L; Fu X; Liu S; Bo X; Yu G
Innovation (Camb); 2021 Aug; 2(3):100141. PubMed ID: 34557778
[TBL] [Abstract][Full Text] [Related]
36. The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis.
Tehranian C; Fankhauser L; Harter PN; Ratcliffe CDH; Zeiner PS; Messmer JM; Hoffmann DC; Frey K; Westphal D; Ronellenfitsch MW; Sahai E; Wick W; Karreman MA; Winkler F
Neuro Oncol; 2022 Feb; 24(2):213-225. PubMed ID: 34216217
[TBL] [Abstract][Full Text] [Related]
37. HepaCAM controls astrocyte self-organization and coupling.
Baldwin KT; Tan CX; Strader ST; Jiang C; Savage JT; Elorza-Vidal X; Contreras X; Rülicke T; Hippenmeyer S; Estévez R; Ji RR; Eroglu C
Neuron; 2021 Aug; 109(15):2427-2442.e10. PubMed ID: 34171291
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
Tawbi HA; Forsyth PA; Hodi FS; Lao CD; Moschos SJ; Hamid O; Atkins MB; Lewis K; Thomas RP; Glaspy JA; Jang S; Algazi AP; Khushalani NI; Postow MA; Pavlick AC; Ernstoff MS; Reardon DA; Puzanov I; Kudchadkar RR; Tarhini AA; Sumbul A; Rizzo JI; Margolin KA
Neuro Oncol; 2021 Nov; 23(11):1961-1973. PubMed ID: 33880555
[TBL] [Abstract][Full Text] [Related]
39. Dermatopontin as a potential pathogenic factor in endometrial cancer.
Huang H; Hao Z; Long L; Yin Z; Wu C; Zhou X; Zhang B
Oncol Lett; 2021 May; 21(5):408. PubMed ID: 33841569
[TBL] [Abstract][Full Text] [Related]
40. TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway.
Sun T; Bi F; Liu Z; Yang Q
J Transl Med; 2021 Mar; 19(1):111. PubMed ID: 33731124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
